AIDS and Behavior

, Volume 14, Issue 5, pp 1023–1031

Risky Sexual Behavior and Correlates of STD Prevalence Among African American HIV Serodiscordant Couples

  • The NIMH Multisite HIV/STD Prevention Trial for African American Couples Group
Original Paper


This paper reports baseline behavioral and biological data collected from a cohort of 535 African American HIV serodiscordant couples enrolled in the Eban study across four urban metro areas. Data were collected on (1) the prevalence of risky sexual behaviors that occur within a couple and with concurrent sexual partners, (2) the STD prevalence for each member of the couple and (3) the correlates of STDs in the male partner as well as in the female partner. Presentation of the sociodemographic characterization and HIV risk behavior profiles of African American HIV serodiscordant couples represents an important initial description of a hidden, vulnerable population. Future research should be conducted with diverse samples of African American couples (i.e., younger couples, non-stable couples) to explore other potential correlates of STD prevalence.


HIV Serodiscordant African-American couples 


  1. 1.
    Weller SC, Davis-Beaty K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev. 2002;(Issue 1):Art. No.:CD003255.Google Scholar
  2. 2.
    Skurnick JH, Abrams J, Kennedy CA, Valentine SN, Cordell JR. Maintenance of safe sex behavior by HIV-serodiscordant heterosexual couples. AIDS Educ Prev. 1998;10(6):493–505.PubMedGoogle Scholar
  3. 3.
    Kalichman SC, Rompa D, Luke W, Austin J. HIV transmission risk behaviours among HIV-positive persons in serodiscordant relationships. Int J STD AIDS. 2002;13(10):677–82.CrossRefPubMedGoogle Scholar
  4. 4.
    Wyatt GE, Longshore D, Chin D, et al. The efficacy of an integrated risk reduction intervention for HIV-positive women with child sexual abuse histories. AIDS Behav. 2004;8(4):453–62.CrossRefPubMedGoogle Scholar
  5. 5.
    Hunt WK, Myers HF, Dyche M. Living with risk: Male partners of HIV-positive women. Cultur Divers Ethnic Minor Psychol. 1999;5(3):276–286.
  6. 6.
    Wasserheit JN. Epidemiological synergy Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis. 1992;19(2):61–77.PubMedGoogle Scholar
  7. 7.
    Wilson TE, Minkoff H, DeHovitz J, Feldman J, Landesman S. The relationship of cocaine use and human immunodeficiency virus serostatus to incident sexually transmitted diseases among women. Sex Transm Dis. 1998;25(2):70–5.CrossRefPubMedGoogle Scholar
  8. 8.
    Wingood GM, DiClemente RJ, Mikhail I, et al. A randomized controlled trial to reduce HIV transmission risk behaviors and sexually transmitted diseases among women living with HIV: The WiLLOW Program. J Acquir Immune Defic Syndr. 2004;37(Suppl 2):S58–67.PubMedGoogle Scholar
  9. 9.
    Bachmann LH, Grimley DM, Waithaka Y, Desmond R, Saag MS, Hook EW III. Sexually transmitted disease/HIV transmission risk behaviors and sexually transmitted disease prevalence among HIV-positive men receiving continuing care. Sex Transm Dis. 2005;32(1):20–6.CrossRefPubMedGoogle Scholar
  10. 10.
    Centers for Disease Control Prevention (CDC). Primary, secondary syphilis—United States, 1999. MMWR Morb Mortal Wkly Rep. 2001;50(7):113–7.Google Scholar
  11. 11.
    Bellamy SL, NIMH Multisite HIV/STD Prevention Trial for African American Couples Study Group. A dynamic block-randomization algorithm for group-randomized clinical trials when the composition of blocking factors is not known in advance. Contemp Clin Trials. 2005;26(4):469–79. doi:10.1016/j.cct.2005.02.005.
  12. 12.
    Caliendo AM, Jordan JA, Green AM, Ingersoll J, Diclemente RJ, Wingood GM. Real-time PCR improves detection of Trichomonas vaginalis infection compared with culture using self-collected vaginal swabs. Infect Dis Obstet Gynecol. 2005;13(3):145–50.CrossRefPubMedGoogle Scholar
  13. 13.
    McFarlane M, St Lawrence JS. Adolescents’ recall of sexual behavior: consistency of self-report and effect of variations in recall duration. J Adolesc Health. 1999;25(3):199–206.CrossRefPubMedGoogle Scholar
  14. 14.
    The National Institute of Mental Health (NIMH) Multisite HIV Prevention Trial Group. The NIMH Multisite HIV Prevention Trial: reducing HIV sexual risk behavior. Science. 1998;280(5371):1889–94.Google Scholar
  15. 15.
    NIMH Collaborative HIV/STD Prevention Trial Group. Challenges and processes of selecting outcome measures for the NIMH Collaborative HIV/STD Prevention Trial. AIDS. 2007;21(Suppl 2):S29–36.Google Scholar
  16. 16.
    Melchior LA, Huba GJ, Brown VB, Reback CJ. A short depression index for women. Educ Psychol Meas. 1993;53:1117–25.CrossRefGoogle Scholar
  17. 17.
    Wyatt GE, Lawrence J, Vodounon A, Mickey MR. The Wyatt Sex History Questionnaire: a structured interview for female sexual history taking. J Child Sex Abus. 1992;1(4):51–68.CrossRefGoogle Scholar
  18. 18.
    Straus MA, Hamby SL, Boney-McCoy S, Sugarman DB. The revised Conflict Tactics Scales (CTS2): development & preliminary psychometric data. J Fam Issues. 1996;17(3):283–316.CrossRefGoogle Scholar
  19. 19.
    Ewing JA. Detecting alcoholism The CAGE questionnaire. JAMA. 1984;252(14):1905–7.CrossRefPubMedGoogle Scholar
  20. 20.
    Peters RH, Greenbaum PE, Steinberg ML, et al. Effectiveness of screening instruments in detecting substance use disorders among prisoners. J Subst Abuse Treat. 2000;18(4):349–58.CrossRefPubMedGoogle Scholar
  21. 21.
    SAS Institute. SAS 9.1.3 help and documentation. Cary, NC: SAS Institute, Inc; 2008.Google Scholar
  22. 22.
    Huhn GD, McIntyre AF, Broad JM, et al. Factors associated with newly diagnosed HIV among persons with concomitant sexually transmitted diseases. Sex Transm Dis. 2008;35(8):731–7.CrossRefPubMedGoogle Scholar
  23. 23.
    Sorvillo F, Smith L, Kerndt P, Ash L. Trichomonas vaginalis, HIV, and African Americans. Emerg Infect Dis. 2001;7(6):927–32.CrossRefPubMedGoogle Scholar
  24. 24.
    Sardana S, Sodhani P, Agarwal SS, et al. Epidemiologic analysis of Trichomonas vaginalis infection in inflammatory smears. Acta Cytol. 1994;38(5):693–7.PubMedGoogle Scholar
  25. 25.
    Kiviat NB, Paavonen JA, Brockway J, et al. Cytologic manifestations of cervical and vaginal infections. I. Epithelial and inflammatory cellular changes. JAMA. 1985;253(7):989–96.CrossRefPubMedGoogle Scholar
  26. 26.
    Fouts AC, Kraus SJ. Trichomonas vaginalis: reevaluation of its clinical presentation and laboratory diagnosis. J Infect Dis. 1980;141(2):137–43.PubMedGoogle Scholar
  27. 27.
    Kreiss J, Willerford DM, Hensel M, et al. Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J Infect Dis. 1994;170(6):1597–601.PubMedGoogle Scholar
  28. 28.
    Stock RJ, Stock ME, Hutto JM. Vaginal douching. Current concepts and practices. Obstet Gynecol. 1973;42(1):141–6.PubMedGoogle Scholar
  29. 29.
    Aral SO, Mosher WD, Cates W Jr. Vaginal douching among women of reproductive age in the United States: 1988. Am J Public Health. 1992;82(2):210–4.CrossRefPubMedGoogle Scholar
  30. 30.
    Snow LF. Traditional health beliefs and practices among lower class black Americans. West J Med. 1983;139(6):820–8.PubMedGoogle Scholar
  31. 31.
    Rajamanoharan S, Low N, Jones SB, Pozniak AL. Bacterial vaginosis, ethnicity, and the use of genital cleaning agents: a case control study. Sex Transm Dis. 1999;26(7):404–9.CrossRefPubMedGoogle Scholar
  32. 32.
    Vermund SH, Sarr M, Murphy DA, et al. Douching practices among HIV infected and uninfected adolescents in the United States. J Adolesc Health. 2001;29(3 Suppl):80–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Funkhouser E, Pulley L, Lueschen G, Costello C, Hook E 3rd, Vermund SH. Douching beliefs and practices among black and white women. J Womens Health Gend Based Med. 2002;11(1):29–37.CrossRefPubMedGoogle Scholar
  34. 34.
    Rosenberg MJ, Phillips RS. Does douching promote ascending infection? J Reprod Med. 1992;37(11):930–8.PubMedGoogle Scholar
  35. 35.
    McClelland RS, Richardson BA, Hassan WM, et al. Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial. J Infect Dis. 2008;197(10):1361–8.CrossRefPubMedGoogle Scholar
  36. 36.
    Krueger LE, Wood RW, Diehr PH, Maxwell CL. Poverty and HIV seropositivity: the poor are more likely to be infected. AIDS. 1990;4(8):811–4.CrossRefPubMedGoogle Scholar
  37. 37.
    Fife D, Mode C. AIDS incidence and income. J Acquir Immune Defic Syndr. 1992;5(11):1105–10.PubMedGoogle Scholar
  38. 38.
    Adimora AA, Schoenbach VJ. Social context, sexual networks, and racial disparities in rates of sexually transmitted infections. J Infect Dis. 2005;191(Suppl 1):S115–22.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • The NIMH Multisite HIV/STD Prevention Trial for African American Couples Group
    • 1
  1. 1.BethesdaUSA

Personalised recommendations